Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
Endophthalmitis after Intravitreal Injection of Triamcinolone Acetonide
Kamppeter B. A., Jonas J. B., Kreissig I., Degenring R. F.
Dept. of Ophthalmology, Faculty for Clinical Medicine Mannheim, University Heidelberg
Purpose: To report the rate of infectious endophthalmitis and post-injection sterile intraocular inflammation after intravitreal injections of triamcinolone acetonide. Design. Interventional case series study.
Method: The study included 327 eyes which consecutively received intravitreal single or repeated injections of 25 mg of triamcinolone acetonide for treatment of edematous, neovascular, proliferative, or inflammatory ocular diseases. With topical anesthesia, the injection was performed in sterile conditions in the operation theater. The solvent agent was removed prior to the injection. Mean follow-up was 5.1 ± 4.7 months (range, one week 23.8 months).
Results: In none of the patients, an injection-related infectious endophthalmitis or a sterile post-injection intraocular inflammation was detected.
Conclusions: If the procedure is performed under sterile conditions in the operation theater, and if the solvent agent is removed, a post-injection endophthalmitis or post-injection intraocular inflammation may only rarely occur.